title: Does the combination of warfarin and aspirin have a place in secondary stroke prevention? Yes.
authors.affiliation: Department of Neurology, Neurological Institute Case Medical Center, Case Western Reserve University School of Medicine, Cleveland, OH 44106, USA. furlana@ccf.org
authors.forename: Anthony J
authors.initials: AJ
authors.lastname: Furlan
mesh_terms: D000925:Anticoagulants / Q000009:adverse effects / Q000627:therapeutic use*; D001241:Aspirin / Q000627:therapeutic use*; D000077144:Clopidogrel; D003692:Delayed-Action Preparations; D004176:Dipyridamole / Q000008:administration & dosage / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006470:Hemorrhage / Q000097:blood / Q000139:chemically induced; D006801:Humans; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D012306:Risk; D020521:Stroke / Q000517:prevention & control*; D013988:Ticlopidine / Q000031:analogs & derivatives / Q000627:therapeutic use; D014859:Warfarin / Q000009:adverse effects / Q000627:therapeutic use*
chemical_list: D000925:Anticoagulants; D003692:Delayed-Action Preparations; D010975:Platelet Aggregation Inhibitors; D014859:Warfarin; D004176:Dipyridamole; D000077144:Clopidogrel; D013988:Ticlopidine; D001241:Aspirin